Postmenopausal atrophic vaginitis. Postmenopausal atrophic vaginitis
Conditions
Interventions
Intervention 1: Intervention group: using of Hormone-free vaginal creams for 8 weeks with an applicator ( Paraffin , hexyl laurate , essence , Aloe Vera) . The first 2 weeks every night in the releva
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Postmenopausal women who have been passed at least 1 year since their last period stopped. The one who have at least one of the vulvovaginal atrophy symptoms such as dryness , burning , itching vulve and vagina and dysparonia Having satisfaction for using each types of medications which offers randomly
Exclusion criteria
Exclusion criteria: Having contraindications of Estrogenic medications such as coronary artery disease , thromboemboli , previous thrombophlebitis , malignancies which are sensitive to Estrogenic-Hormone receptors like breast cancer , endometr or ovaries cancers. using hormonal or vaginal medications in last 6 months using other vaginal products or hormonal tablets infections or vulvovginal lesions such as psoriasis , lichen planus , lichen sclerosis abnormal pap smear results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vulvovaginal dryness. Timepoint: Before intervention and after 8 weeks of using according to the given prescription. Method of measurement: Subjective description by 0-4 ( 0: none , 1: mild , 2: moderate, 3: severe , 4 : very severe ).;Vulvovaginal burning. Timepoint: Before intervention and after 8 weeks of using according to the given prescription. Method of measurement: Subjective description by 0-4 ( 0: none , 1: mild , 2: moderate, 3: severe , 4 : very severe ).;Vulvovaginal itching. Timepoint: Before intervention and after 8 weeks of using according to the given prescription. Method of measurement: Subjective description by 0-4 ( 0: none , 1: mild , 2: moderate, 3: severe , 4 : very severe ).;Dyspareunia. Timepoint: Before intervention and after 8 weeks of using according to the given prescription. Method of measurement: Subjective description by 0-4 ( 0: none , 1: mild , 2: moderate, 3: severe , 4 : very severe ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoume Dadashaliha
Qazvin University of Medical Sciences
Outcome results
None listed